O’Neil Health Care Weekly

XLV’s RS line ( vs S&P 500 ) moved back up last week as majority of the large-cap Health Care ideas are at or
approaching new highs. Health Care remained the best performing sector over the last five days.

Large-cap pharmaceutical and biotech ideas are either forming the right sides of their respective bases or breaking out
into new highs. However, medical devices and diversified ideas including ABT and TMO are pulling back, with their RS
line remaining near lows.

Market View

The U.S. market remains in an Uptrend Under Pressure. The S&P 500 is testing resistance at its 21-DMA (4,167)

after a sharp pullback to and subsequent bounce off support at its rising 50-DMA. The Nasdaq is testing re-
sistance at its 50-DMA (13,579) after a rally across oversold growth constituents. The distribution day count re-
mains elevated at nine and five, respectively. However, two days will expire on the S&P 500 and one on the

Nasdaq next week.

O’Neil Health Care Weekly

XLV’s RS line (vs S&P 500) moved back up last week as majority of the large-cap Health Care ideas continued
to rise. Multiple ideas cleared above their key moving averages and are now forming the right sides of their
respective bases. Earnings session has almost come to an end. On an average, S&P 500 Health Care ideas beat consensus
revenue and EPS by 3% and 13%, respectively in Q1.

Market View

The U.S. market remains in an Uptrend Under Pressure. The S&P 500 bounced off its 50-DMA after a sharp

selloff earlier this week. The Nasdaq, which is already below its key moving averages, is bouncing into re-
sistance at the converging 50- (13,540) and 100-DMA. The distribution day count stands at seven and four re-
spectively, with one day expiring on the S&P 500 next week.

O’Neil Health Care Weekly

XLV’s RS line (vs S&P 500) moved back up last week after multiple large-cap Health Care ideas reported beatand-raise quarters and cleared back above key moving averages.

More than 100 Health Care ideas over $1B in market cap reported last week.

O’Neil Health Care Weekly

XLV’s RS line ( vs S&P 500 ) pulled back last week after multiple near-term extended Health Care ideas
consolidated gains over the last several weeks. Ideas that ran into extended levels pre-print pulled back postprint despite many reporting better-than-expected results. Despite losing some momentum, overall action
remains constructive with few ideas breaking important levels of support.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 made another new all-time high Thursday, moving back above its upper channel line and more than 5% above its 50-DMA before pulling back from extended levels Friday. The Nasdaq briefly touched a new all-time intraday high Thursday, before also pulling back on Friday. We continue to view short-term support at the rising 21-DMA for both indices. The distribution day count stands at four and three, respectively, with no expiration for two full weeks.

O’Neil Health Care Weekly

Over the last five sessions, Commercial Services ( HCSG ), Systems/Equipment ( SWAV ), and Drug Suppliers
( PETQ ) led, while Generic Drugs ( TEVA ), Services ( IRTC ), and Long-term Care ( ENSG ) lagged.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq closed relatively flat for the week
after each held support along short-term moving averages. The S&P 500 rallied off its 10-DMA Friday to close

back at its upper channel line, while the Nasdaq held its 21-DMA before moving back toward all-time high re-
sistance at 14,175. The distribution day count stands at four each with one expiring on the S&P 500 and two on

the Nasdaq next week.